Welcome to
MASLD
RAISING AWARENESS ABOUT METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN YOUNG ADULTS
What is Metabolic dysfunction-associated steatotic liver disease?
Risks and Prevention
Early Symptoms and Treatment
Metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition in which excess fat builds up in the liver of people who drink little to no alcohol. MASLD is increasingly common around the world, especially in Western nations. In the United States, it is the most common form of chronic liver disease, affecting an estimated 80 to 100 million people. Click here to learn more about MASLD and its link to obesity, insulin resistance, and other risk factors.
Raising awareness is the key to prevention and early detection of Metabolic dysfunction-associated steatotic liver disease.
/ DiseaseAwareness.ca
RISKS AND PREVENTION
Metabolic dysfunction-associated steatotic liver disease can lead to serious health problems, including liver damage, cirrhosis, and liver cancer. However, MASLD is preventable and treatable. Click here to learn about the risk factors for MASLD and the steps you can take to reduce your risk.
EARLY SYMPTOMS AND TREATMENT
Metabolic dysfunction-associated steatotic liver disease often has no symptoms in its early stages. However, as the disease progresses, symptoms such as fatigue, abdominal pain, and yellowing of the skin may occur. Treatment for MASLD focuses on managing the underlying risk factors and preventing further liver damage. Click here to learn more about the symptoms of MASLD and the available treatments.